Alert New Option for Constipation: FDA Approves Linaclotide The once-daily drug shows efficacy over placebo in reducing both chronic constipation and constipation associated with irritable bowel ...

Despite more treatments and heightened awareness, Americans with irritable bowel syndrome (IBS) report worsening impacts on work, home, and social life compared with a decade ago. A new survey from ...

Silicolgel, a colloidal silicic acid enterosorbent, was generally safe and well tolerated, and it significantly reduced symptom severity in adults with irritable bowel syndrome, with efficacy being ...

An elimination diet guided by a novel irritable bowel syndrome (IBS)–specific immunoglobulin G (IgG) assay reduced abdominal pain in a greater proportion of patients with IBS than a sham elimination ...

For adults with irritable bowel syndrome (IBS), combining a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) and a gluten-free diet (GFD) appears to ...

Acute gastroenteritis increases the odds of developing functional dyspepsia (FD) and irritable bowel syndrome (IBS), with the latter lasting 1-4 years in half of patients after the infection.

An analysis of irritable bowel syndrome (IBS)-related posts on X reveals discussions spanning symptoms, dietary triggers, peer support, and mental health — suggesting that traditional healthcare ...

COVID Raises Risk for Long-Term GI Complications Overall, patients infected with the virus had a 36% higher risk of developing GI conditions. Medscape Medical News, March 13, 2023 Are You ...